A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

NCT06224192 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

COMBINATION_PRODUCT: Rocatinlimab Prefilled Syringe
COMBINATION_PRODUCT: Rocatinlimab AI

Sponsor

Amgen